ARCHIVES

On “Day One Of Post-Genome World,” Eric Lander Recounts 15-Year Journey.

This article is from The Cancer Letter archive.

Vol. 27 No. 07 | February 16, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: John Minton Dies Forom Auto Accident Injuries; FDA Rules Against Generic Megastrol Acetate

January 11, 1991

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

July 27, 2001

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

DeVita Emphasizes NCI Prevention In Statement To Senate Committee

February 15, 1980

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

Scientists, Public Citizen Urge FDA To Ban Sale Of Obesity Drug Orlistat.

June 2, 2006